Invitro Diagnostics, Reagents, Test (FSS-65-VII)

Award Date 5/15/2005
Last Date To Order 10/31/2023
Shared Ceiling Not listed
Contract Type
Master GSA Schedule
Predecessor
Not listed
Successors

This Master GSA Schedule (FSS-65-VII) for In Vitro Diagnostics, Reagents, and Test Kits is a comprehensive contract vehicle facilitating the procurement of clinical diagnostic products and services for federal healthcare agencies. The vehicle covers a wide range of medical testing supplies, including blood bank reagents, glucose monitoring equipment, molecular diagnostic test kits, point-of-care testing devices, and associated consumables. Contractors provide specialized laboratory testing technologies and supplies that support critical healthcare operations across multiple federal healthcare networks, with a primary focus on enabling diagnostic testing, disease detection, and patient care management.

The task orders under this vehicle predominantly involve the Department of Veterans Affairs (VA), with contracts typically ranging from $10,000 to $1,000,000 and performance periods of 12 to 60 months. Frequent prime contractors include Abbott Laboratories, Roche Diagnostics, Biomerieux Inc., Immucor Inc., and Fisher Scientific Company. Most task orders are firm-fixed-price Blanket Purchase Agreements (BPAs) or delivery orders, with no specific small business set-asides. The contracts primarily support VA Veterans Integrated Service Networks (VISNs), with some additional orders from the Indian Health Service, Defense Health Agency, and National Institutes of Health. Common product categories include glucose testing supplies, blood bank reagents, molecular diagnostic panels, point-of-care testing equipment, and microbiology media and test kits.

Generated 1/16/25, 12:13 AM